
Ultragenyx
Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
About
Ultragenyx is a biopharmaceutical company dedicated to developing and delivering transformative treatments for rare and ultrarare genetic diseases where no current options exist. They explore various drug modalities to create the best treatment strategy for each genetic disease they study, serving patients globally. The company is committed to advancing innovative medicines and has a robust pipeline of therapies in development.
Similar companies
Developing genetic medicines and cell therapies for severe diseases using proprietary CRISPR OMNI technology.
Shares Biotech, MedTech
A biotechnology company developing genetic therapies for rare disorders.
Shares Drug Discovery, Clinical Trials
A biopharmaceutical company focused on developing and commercializing therapies for rare diseases.
Shares Drug Discovery, Clinical Trials
Leveraging the adaptive immune system to diagnose and treat disease.
Shares Biotech, HealthTech
A global oncology company developing and commercializing innovative cancer treatments.
Shares Biotech, MedTech
Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
Shares Biotech, MedTech
Key facts
- Website
- ultragenyx.com
- Headquarters
- Novato, United States
- Founded
- 2010
- Employees
- 1,498
- Business model
- B2B
Tech stack
Detected on ultragenyx.com, last scanned 7 Nov 2026. Run your own scan
- Frontend
- Tailwind CSS
- CDN
- Cloudflare
- Email provider
- Mimecast
- Email marketing
- Salesforce Pardot
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Ultragenyx trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Ultragenyx is 82 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does Ultragenyx have?
Ultragenyx has approximately 1,498 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Ultragenyx:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules


